Pharmacology of Lipid-Lowering Drugs
29 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What type of drugs inhibit platelet function?

  • Pain relievers
  • Anti-inflammatory drugs
  • NSAIDs (correct)
  • Anticoagulants
  • What is a common side-effect of warfarin?

  • Nausea
  • Hemorrhage (correct)
  • Skin rash
  • Diarrhea
  • Can warfarin be used in breast-feeding mothers?

  • Only in low doses
  • Only in emergency situations
  • No
  • Yes (correct)
  • What is a rare side-effect of warfarin?

    <p>Skin necrosis</p> Signup and view all the answers

    What is the name of the oral anticoagulant mentioned in the text?

    <p>Warfarin</p> Signup and view all the answers

    Why does warfarin increase the risk of hemorrhage?

    <p>It decreases protein C biosynthesis</p> Signup and view all the answers

    What is a teratogenic effect of warfarin?

    <p>Birth defects</p> Signup and view all the answers

    When does warfarin cause skin necrosis?

    <p>When it is first started</p> Signup and view all the answers

    What is the effect of warfarin on protein C biosynthesis?

    <p>It decreases it</p> Signup and view all the answers

    What is a potential complication of thrombosis in venules?

    <p>Skin necrosis</p> Signup and view all the answers

    What is a benefit of DOACs compared to Vitamin K antagonists?

    <p>They offer greater convenience to patients</p> Signup and view all the answers

    What is a symptom associated with thrombosis in venules?

    <p>Purple toes</p> Signup and view all the answers

    What is a characteristic of DOACs?

    <p>They have a fixed dosing regimen</p> Signup and view all the answers

    What is a common location where thrombosis may occur?

    <p>Venules</p> Signup and view all the answers

    What is a complication of thrombosis in venules?

    <p>Skin necrosis</p> Signup and view all the answers

    What type of anticoagulants are DOACs?

    <p>Direct oral anticoagulants</p> Signup and view all the answers

    What is a benefit of DOACs over Vitamin K antagonists?

    <p>They offer greater convenience</p> Signup and view all the answers

    What is a characteristic of thrombosis in venules?

    <p>It can lead to skin necrosis</p> Signup and view all the answers

    What is a symptom associated with thrombosis?

    <p>Purple discoloration of the toes</p> Signup and view all the answers

    What is warfarin primarily used to prevent?

    <p>Venous thromboembolism</p> Signup and view all the answers

    What is monitored in patients taking warfarin?

    <p>International normalised ratio (INR)</p> Signup and view all the answers

    What is the purpose of measuring the INR in patients taking warfarin?

    <p>To monitor the effectiveness of warfarin</p> Signup and view all the answers

    What is the name of the ratio used to monitor warfarin's effectiveness?

    <p>International normalised ratio (INR)</p> Signup and view all the answers

    What is a common indication for warfarin therapy?

    <p>Atrial fibrillation</p> Signup and view all the answers

    Why is warfarin considered a narrow therapeutic index drug?

    <p>Because it has a narrow range of effective doses</p> Signup and view all the answers

    What is the purpose of taking warfarin in patients with mechanical heart valves?

    <p>To prevent blood clots from forming on the valve</p> Signup and view all the answers

    What is the relationship between the INR and the prothrombin time?

    <p>The INR is the ratio of the prothrombin time to the normal prothrombin time</p> Signup and view all the answers

    What is the indication for warfarin therapy in patients with venous thromboembolism?

    <p>To prevent the formation of additional blood clots</p> Signup and view all the answers

    What is the primary goal of warfarin therapy?

    <p>To prevent the formation of blood clots</p> Signup and view all the answers

    Study Notes

    Lipid-Lowering Drugs

    • HMG-CoA reductase inhibitors, PCSK9 MAB, niacin, ezetimibe, and resins are used to treat hyperlipidemias, such as secondary sarcoidosis.
    • These drugs work by reducing cholesterol levels, leading to increased bile acid synthesis.

    Pulmonary Arterial Hypertension (PAH)

    • Exertional dyspnea is the most common symptom of PAH.
    • Chest pain and syncope may also occur.
    • Characteristic physical examination findings include loud P2 (Pulmonic closure sound) and left parasternal heave (due to right ventricular hypertrophy).

    Management of PAH

    • Treatment should first involve addressing any underlying conditions, such as with anticoagulants or oxygen.
    • If there is a positive response to acute vasodilator testing, oral calcium channel blockers can be used.

    Pathophysiology of PAH

    • Three pathways are involved in the development of PAH:
      • Nitric oxide pathway
      • Prostacyclin pathway
      • Endothelin pathway

    Anticoagulants

    • Warfarin is an oral anticoagulant with a long half-life, requiring several days to achieve a stable INR.
    • Factors that may potentiate warfarin:
      • Liver disease
      • P450 enzyme inhibitors (e.g., amiodarone, ciprofloxacin)
      • Cranberry juice
      • Drugs that displace warfarin from plasma albumin (e.g., NSAIDs)
      • Drugs that inhibit platelet function (e.g., NSAIDs)
    • Side effects of warfarin:
      • Hemorrhage
      • Teratogenic effects (although safe for breast-feeding mothers)
      • Skin necrosis (when warfarin is first started, biosynthesis of protein C is reduced)

    Acute Vasodilator Testing

    • Aims to determine which patients show a significant fall in pulmonary arterial pressure following vasodilator administration
    • Vasodilators used: IV Epoprostenol, inhaled nitric oxide, prostacyclin analogues (iloprost, treprostinil), and phosphodiesterase-5 (PDE-5) inhibitors (sildenafil)

    Blood Coagulation

    Platelet Aggregation and Blood Coagulation

    • Involved in antiplatelet drugs and anticoagulants

    Antiplatelet Drugs

    • No specific information provided

    Anticoagulants

    Injectable Anticoagulants

    • Standard heparin: administered intravenously, short duration of action, side effects include bleeding, heparin-induced thrombocytopenia (HIT), and osteoporosis
    • Low molecular weight heparin (LMWH): administered subcutaneously, long duration of action, side effects include bleeding, lower risk of HIT and osteoporosis

    Monitoring

    • Standard heparin: monitored using activated partial thromboplastin time (APTT)
    • LMWH: monitored using anti-Factor Xa (although routine monitoring is not required)
    • Heparin overdose may be reversed by protamine sulphate, although this only partially reverses the effect of LMWH

    Indications

    • Venous thromboembolism
    • Atrial fibrillation
    • Mechanical heart valves

    Oral Anticoagulants

    Warfarin

    • Monitored using the INR (international normalised ratio)
    • Has a long half-life, achieving a stable INR may take several days
    • Factors that may potentiate warfarin:
      • Liver disease
      • P450 enzyme inhibitors (e.g. amiodarone, ciprofloxacin)
      • Cranberry juice
      • Drugs that displace warfarin from plasma albumin
    • Thrombosis may occur in venules, leading to skin necrosis and purple toes

    Direct Oral Anticoagulants (DOACs)

    • Have a fixed dosing regimen and do not require frequent monitoring
    • Offer greater convenience to patients compared to Vitamin K antagonists (e.g. warfarin)

    Disorders of Lipid Metabolism

    • Disorders of lipid metabolism can occur as primary conditions (familial or polygenic) or secondary to an underlying disease state or drug treatment.
    • Risks of dyslipidemias include increased risk of atherosclerosis, ischaemic heart disease, cerebrovascular disease, and peripheral vascular diseases, directly related to increasing levels of serum cholesterol.

    Management of Dyslipidemias

    • Increase intake of unsaturated fats (e.g., olive oil, salmon, cashews, almonds) to help manage dyslipidemias.
    • Increase physical activity to reduce risks of dyslipidemias.

    Lipid-Lowering Drugs

    • Statins: inhibit HMG CoA reductase, reducing cholesterol synthesis; examples include Atorvastatin, Simvastatin, and Rosuvastatin; adverse effects include muscle pain (myositis) and liver damage.
    • Ezetimibe: decreases cholesterol absorption in the small intestine; adverse effects include headache.
    • Nicotinic acid (Niacin, Vit B3): decreases hepatic VLDL secretion; adverse effects include myositis and flushing.
    • Fibrates: agonist of PPAR-alpha, increasing lipoprotein lipase expression; examples include Gemfibrozil and Fenofibrate; adverse effects include myositis, pruritus, and cholestasis.
    • Cholestyramine: binds bile acid, decreasing reabsorption in the small intestine; adverse effects include GI side-effects.

    Pulmonary Arterial Hypertension (PAH)

    • Defined as a sustained elevation in mean pulmonary arterial pressure (>25 mmHg at rest or >30 mmHg after exercise).
    • Acute vasodilator testing: decides which patients show a significant fall in pulmonary arterial pressure following vasodilator administration (e.g., IV Epoprostenol or inhaled nitric oxide).
    • Indications for PAH treatment include venous thromboembolism, atrial fibrillation, and mechanical heart valves.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    This quiz covers the sites of action of various lipid-lowering drugs, including HMG-CoA reductase inhibitors, PCSK9 MAB, niacin, ezetimibe, and resins, used to treat hyperlipidemias. Understand the mechanisms of these drugs in reducing cholesterol levels.

    More Like This

    Drug Classification and Mechanisms
    190 questions
    Pharmacology of Lipid-Lowering Agents
    39 questions
    Use Quizgecko on...
    Browser
    Browser